Skip to main content
Clinical Trials/TCTR20221129002
TCTR20221129002
Unknown
Phase 1

A randomized clinical trial on the antimicrobial activity and safety of 0.5% chitosan mouth spray

Faculty of Dentistry, Khon Kaen University0 sites60 target enrollmentNovember 29, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Healthy with ASA (American association of Anesthesiologists) class 1 and class 2
Sponsor
Faculty of Dentistry, Khon Kaen University
Enrollment
60
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 29, 2022
End Date
June 6, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of Dentistry, Khon Kaen University

Eligibility Criteria

Inclusion Criteria

  • 1\. ASA (American association of Anesthesiologists) class 1 and class 2
  • 2\. at least 10 teeth in the mouth

Exclusion Criteria

  • 1\. Chitosan allergy
  • 2\. Preservatives or flavoring agents for allergy
  • 3\. High\-risk caries
  • 4\. Gingival bleeding index of more than 15%
  • 5\. Dental crowns or bridges
  • 6\. Pathologic oral lesion
  • 7\. Received antibiotics, steroids, or immunosuppressants within the last 3 months
  • 8\. Pregnant or breastfeeding
  • 9\. Alcohol consumption
  • 10\. Smoking, marijuana, or other drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials